Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 July, 2018 15:28 IST
Strides Shasun gets USFDA nod for Potassium Citrate ER tablets
Source: IRIS | 12 Sep, 2017, 10.15AM
Comments  |  Post Comment

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq.

According to IMS data, the US market for Potassium Citrate is approximately USD 110 million.

The company will be the second generic player to commercialize the product. The product, which is the first approval for an Extended Release tablet for the company, will be launched immediately.

Potassium Citrate, a urinary alkalinizing agent, is used for preventing certain types of kidney stones. It works by neutralizing some of the acid in the urine, which helps reduce the formation of crystals. 

Shares of the company gained Rs 28.7, or 3.05%, to trade at Rs 970.00. The total volume of shares traded was 46,320 at the BSE (9.58 a.m., Tuesday).



Strides Shasun Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Tata Motors bags order to supply EVs to Cognizant - 19-Jul-2018 13:19
Infosys Foundation signs accord with Bangalore Metro - 19-Jul-2018 11:49
Lupin gets tentative FDA approval for generic Tadalafil Tablets USP - 19-Jul-2018 11:34
Zydus receives final approval from USFDA for Piroxicam Capsules USP - 19-Jul-2018 10:26
MCX takes preventive measures against technical glitches - 19-Jul-2018 10:19
Tata Power launches electric vehicle charging stations in Hyderabad - 18-Jul-2018 15:45
Kridhan Infra VNC's JV bags order worth Rs 2.22 bn - 18-Jul-2018 12:38
Sun Pharma gets USFDA approval of INFUGEM injection - 18-Jul-2018 12:02
PNC Infratech signs concession agreement with NHAI for road project in Karnataka - 18-Jul-2018 11:32
Zydus receives four consecutive ANDA approvals from USFDA - 18-Jul-2018 10:55
Indian TSPs to build efficient infra service for swift growth:Study - 17-Jul-2018 17:27
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer